KCG
NVAX icon

Knight Capital Group’s Novavax NVAX Stock Holding History

Knight Capital Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$31K Buy
+764
New +$33.1K ﹤0.01% 3123

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

Knight Capital Group's NVAX Position: Q2 2013 in Review

Knight Capital Group opened a new position in Novavax (NVAX) in Q2 2013: 764 shares worth $31K. The stake represents ﹤0.01% of the portfolio and ranks #3123 among its holdings.

89 funds tracked by Wall St. Rank hold NVAX as of Q2 2013.

  • Knight Capital Group held 764 shares of Novavax worth $31K as of Q2 2013.
  • Novavax was a new Knight Capital Group position in Q2 2013.
  • Novavax made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3123 holding.
  • 89 funds tracked by Wall St. Rank held Novavax as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.